Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Who Does the Best Deep Plane Facelift in Florida?
-
B2Gold Reports Update on Fire-Related Incident to the Crushing Circuit at the Goose Mine
-
Jacob Wheeler Wins Major League Fishing’s Bass Pro Shops REDCREST 2026 Presented by Mercury and Lowrance at Table Rock Lake
-
Douce Vallée Expands B2B Operations with Bespoke Corporate Gifting and Event Dessert Services in Hong Kong
-
4/20 and the Future of Cannabis Medicine: Why Botanical Therapies Must Meet Real Scientific Standards
-
Mitsubishi Electric to Launch Railway Energy Management Solution Proof of Concept for Krakow Tram Network in Poland
-
Attention Long-Term e.l.f. Beauty, Inc. (ELF) Shareholders: Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Survives Motion to Dismiss
-
ITRI Earns Five 2026 Edison Awards
-
Simpli5 Announces Platform Expansion Designed to Close the Gap Between Self-Awareness and Team Action
-
EPG Publishes Inaugural ESG Report, Establishing Baseline for Sustainable Global Expansion
-
SkyDrive Becomes Japan’s First eVTOL Developer to Earn “Approved Design Organization” (ADO) Certification
-
Leapmotor Selects QNX for D19 Premium Electric SUV, Production Starts April 2026
-
Duncan Brand Announces Release of “Mind the Gap,” Addressing Gaps in Leadership Development Practices
-
Foutz finds late-day kicker for Bassmaster Elite win at Arkansas River
-
SQRIL Expands to Africa with Launch of Stablecoin-to-Fiat QR Payments and Mobile Money Integration in Tanzania, Kenya, and South Africa
-
BIGC Targets Global Live Market with Its All-in-One Digital Venue, Achieving 1,028% Growth in Three Years
-
First Challenger Assays Return Grades up to 170g/t Au
-
CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3)
-
Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Round
-
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
-
Faraday Future Announces $45 Million in New Financing with a U.S. Institutional Investor to Strongly Support the Execution of Its EAI Robotics & EAI EV Business; Plans to Pursue Long-Term Strategi
-
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
-
New Report Highlights the Financial and Human Costs of Fragmented Health Data Across the United States
-
SK hynix Begins Mass Production of 192GB SOCAMM2 'Setting a New Standard for AI Server Memory Performance'
-
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
-
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
-
CoreAge Rx Earns Strong Trustpilot and BBB Recognition While Advancing Patient-Centered Weight Management Care
-
Horse Powertrain Reveals X-Range C15 Direct Drive Powertrain for Hybridizing BEV Platforms
-
Amplitude Research Reveals a Generational AI Trust Gap is Costing Australian Businesses
-
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
-
Best’s Market Segment Report: Australia’s Non-Life Insurance Segment Navigating Growth in a Volatile Landscape
-
Synthetic Design Lab Unveils First Advanced Logic-Gated ADC at AACR 2026, Achieving ≥10X Improvement in Targeted Cancer Cell Killing
-
Northwyn Wellness Group Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
-
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
-
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
-
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
-
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
-
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
-
Paywint Showcases Advanced Payments Technology Capabilities Ahead of Money20/20 Asia
-
EpiBiologics Doses First Patient with EPI-326 Bispecific Antibody in Global Phase 1 Study for EGFR-Driven Solid Tumors
-
Sidus Space Announces Pricing of $58.5 Million Registered Direct Offering of Class A Common Stock
-
Cloverleaf Analytics Unveils 2026 Insurance Decision Intelligence Platform
-
BrightParent Introduces Personalized Parenting App for Parents of Kids Ages 5 to 17
-
The Light System and Jason Shurka Win in Federal Court as EES Lawsuit Is Dismissed
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
TEAMSTERS AT UNIVERSITY OF CHICAGO MEDICAL CENTER TO HOLD TWO-DAY PRACTICE PICKET
-
In HelloNation, Criminal Defense Attorney Mitchell A. Stone, P.A. Explains Plea Deals
-
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026
-
EPAS Says U.S. Representation Gap at ICAO Risks Foreign and Special-Interest Influence on Aviation Decisions
-
SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
